Nabeel Aslam

Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy

Fernando C. Fervenza, Gerald B. Appel, Sean J. Barbour et al. · New England Journal of Medicine · 2019 · 554 citations · Full text

Dual endothelin antagonist aprocitentan for resistant hypertension (PRECISION): a multicentre, blinded, randomised, parallel-group, phase 3 trial

Markus P. Schlaich, M Bellet, Michael A. Weber et al. · The Lancet · 2022 · 206 citations · Full text

Molecular Pharmacology, Hypertension, Resistant Hypertension +9

Comparison of Infectious Complications between Incident Hemodialysis and Peritoneal Dialysis Patients

Nabeel Aslam, Judith Bernardini, Linda F. Fried et al. · Clinical Journal of the American Society of Nephrology · 2006 · 141 citations · Full text

Dialysis Modality, Dialysis, Dialysis Therapy +16

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs et al. · European Heart Journal · 2021 · 118 citations · Full text

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text